At present, prices have been fixed for 856 formulations, including four medical devices, which are covered under Schedule–I of the Drug Price Control Orders (DPCO), 2013.
Price caps on drugs helped patients save Rs 11.5k cr: Government
More from Industry NewsMore posts in Industry News »
- Sanofi and Translate Bio start clinical trial for mRNA flu vaccine
- Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US
- Bharat Biotech’s Covaxin gets SEC approval on its Phase 3 trials efficacy data
- Covid-19 has highlighted the Indian pharma industry’s potential in transforming into an innovation hub: Sudarshan Jain